In advanced melanoma patients, PD-1 is upregulated transiently and often sequentially by neoantigen-specific CD8+ T cells upon T-cell activation and exposure to common gamma-chain cytokines including IL-2 in vitro (20). The gene discussed is IL2; the disease is melanoma.